Gas Chromatography Market Segmentation:
End user Segment Analysis
The pharmaceuticals & bio industries segment in the gas chromatography market is estimated to gain a robust revenue share of 42% in the throughout the forecast years. The segment’s notable captivation is majorly attributed to the increasing demand for these systems in drug discoveries and broad applications. GC is frequently utilized in the pharmaceutical and biotechnology R&D for quality control objectives and to find contaminants in active pharmaceutical ingredients (APIs). Besides, this is also used in the bio-analysis of blood and urine samples for detecting barbiturates, alcohols, narcotics, residual solvents, drugs such as anesthetics, and antihistamines. Furthermore, GC systems are highly desired to identify toxins and venoms, making them an essential tool in the clinical toxicology industry.
Product Segment Analysis
The accessories & consumables segment is set to garner a notable share in the gas chromatography market by 2035. The steady surge for these companion commodities is fueled by their limited durability. Accessories, such as columns, fittings, pipes, and others are accumulatively generating significant revenue, solidifying this segment’s leadership. Moreover, innovations in this segment are anticipated to create numerous opportunities global leaders. For instance, in April 2024, Waters Corporation launched GTxResolve Premier Size Exclusion Chromatography 1000Å 3-micron Columns, escalating the pace of gene-based therapeutics production.
Our in-depth analysis of the global gas chromatography market includes the following segments:
|
Product |
|
|
End user |
|
